semaglutide + tirzepatide Hair loss with GLP-1 drugs is rare but real, studies find (copy) I started my Tirzepatide journey

Diabetes mellitus and impaired pancreatic beta-cell proliferation

TRIUMPH-4, the first completed Phase 3 trial, showed 28.7% average body weight loss at 68 weeks on retatrutide 12mg versus 2.1% on placebo, as reported by Eli Lilly in December 2025 (peer-reviewed publication pending)

Avoid stacking MOTS-C with multiple peptides that all hit similar receptors

Ask for copies of ER records, imaging results, and specialist notes that may indicate side effects such as gastroparesis, stomach paralysis, or vision loss related to NAION

This may be true if: Weight loss is still progressing Metabolic markers are still improving Hormonal imbalances remain untreated Life stress is unusually high Sleep is severely disrupted There is no timeline you must follow

Look at Other Choices : If our coverage aint cutting it, check out options like compounded versions